GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Nov 15, 2021 · 10-Q · 46 days after period end · 0001818331-21-000012
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $43.18M | $38.61M |
| Net Income | $32.73M | -$56.62M |
| EPS Diluted | $0.16 | -$456,573.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end
